slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 43,501-43,530
Pages 2,019
Rows per page 30
Component
43,501-43,530 of 60,568
38
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
39
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
41
The slide uses a three-row table layout to categorize governance highlights.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
42
The slide uses a checkmark matrix to demonstrate board competency across 12 distinct business domains.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
43
Includes a legend for blue dots indicating directors joined since 2018 and a footer note regarding age calculation date.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
49
The table includes both financial figures in millions and vehicle counts in thousands.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
51
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
52
Includes a standard non-GAAP financial measure disclaimer.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
53
Includes a detailed disclosure paragraph explaining the calculation and use of Segment EBITDA.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations Loop · Mece Breakdown1 hit
54
Includes footnotes regarding Uni-Select acquisition and Ukraine/Russia conflict impacts.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
56
Contains footnotes regarding Uni-Select acquisition and Ukraine/Russia conflict impacts.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
58
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
59
Includes footnote regarding Uni-Select acquisition.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
60
Includes a footnote regarding the exclusion of gains from the sale of businesses in FCF conversion.LKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
61
LKQ | Results Presentation Deck | 62 slidesLKQ | Results Presentation Deck | 62 slides · LKQ
Conference presentation Investor relations 1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo across efficacy, safety, and administration metrics.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
15
The slide compares the safety profile of THIO against standard of care (SOC) chemotherapy.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
16
DCR stands for Disease Control Rate. The table compares historical benchmarks (Standard of Care) against the company's clinical trial results (THIO-101).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
17
Data presented in a table format with footnotes explaining the methodology for DCR calculation.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Traction1 hit
25
The slide compares clinical trial data for three different treatment regimens in CRC patients.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
26
The table compares historical standard of care data against planned THIO-102 trial outcomes.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
27
The table compares an existing standard of care (Zepzelca) against the company's planned trial (THIO-102).MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
34
The slide includes specific details on options, warrants, and insider ownership percentages.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
37
The slide uses a table-like layout to associate logos with market cap figures, followed by specific acquisition deal context.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pareto Focus1 hit
38
Includes detailed breakdown of investment income, expenses, non-cash compensation, and net asset changes.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
39
The table tracks the bridge from beginning NAV to ending NAV per share, including income, expenses, dividends, and share issuance impacts.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
40
Includes footnotes regarding credit facilities and specific notes payable details.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
41
Includes detailed footnotes explaining debt components and ratio calculation methodologies.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations Beat · Financials1 hit
42
The slide highlights a conservative capital structure with a mix of floating and fixed-rate debt.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit
44
The table shows a clear asymmetric impact due to interest rate floors on the investment side.Main Street Capital | Investor Presentation Deck | 49 slides · Main Street Capital Corporation
Pitch deck Investor relations 1 hit